Share Tweet Pocket Add to Bookmarks
You're reading: Ukraine’s Biofarma opens new $40 million drug-making center
Popular
on social media

A maker of
immunological and other pharmaceuticals, Biofarma built the production center from the
ground up in 2.5 years, company chairman Oleksandr Makovsky said.

The project stems
from an infusion of cash that the Kyiv-based company received in exchange for
stakes in October 2012 from Holland’s development bank FMO and Ukraine-based
private equity fund manager Horizon Capital.

Exclusive article

Sign up or subscribe to view more articles.
See All Plans
$5.95
Monthly plan
Get unlimited article access, anytime, anywhere.

Subscribe
$60
Yearly plan
Access all the exclusive content on KyivPost.com and the complete online archive.
Subscribe
Advertisement

Add comment

Sorry, you must be logged in to post a comment.
More in this section
Attention

Add a picture
Choose file
Add a quote
Attention

Are you sure you want to delete your comment?

Attention

Are you sure you want to delete all user's comments?

Attention

Are you sure you want to unapprove user's comment?

Attention

Are you sure you want to move to spam user's comment?

Attention

Are you sure you want to move to trash user's comment?

Spelling error report

The following text will be sent to our editors: